Copyright
©The Author(s) 2025.
World J Gastroenterol. Aug 14, 2025; 31(30): 110401
Published online Aug 14, 2025. doi: 10.3748/wjg.v31.i30.110401
Published online Aug 14, 2025. doi: 10.3748/wjg.v31.i30.110401
Table 6 Changes in differential metabolites before and after artificial liver blood purification system treatment
Metabolite | ALBPS | P value | VIP | |
Before | After | |||
Ala | 370.58 ± 143.66 | 548.53 ± 339.56 | 0.025 | 1.88 |
L-carnitine | 69.79 ± 40.90 | 101.68 ± 70.24 | 0.067 | 1.36 |
Arg | 22.48 ± 9.56 | 22.95 ± 9.57 | 0.87 | 0.91 |
Creatinine | 90.21 ± 44.44 | 112.29 ± 69.86 | 0.208 | 0.88 |
Pro | 303.03 ± 106.05 | 324.23 ± 171.56 | 0.617 | 0.79 |
C18:1 | 459.80 ± 304.72 | 350.58 ± 243.92 | 0.186 | 0.7 |
Choline | 81.41 ± 39.88 | 89.30 ± 61.74 | 0.609 | 0.41 |
- Citation: Liu Y, Xiao Y, Ai LF, Zhang JJ, Zhang JD, Qi ZQ, Dong L, Wang YD. Serum metabolomic characteristics and their predictive value for ninety-day prognosis in patients with acute-on-chronic liver failure. World J Gastroenterol 2025; 31(30): 110401
- URL: https://www.wjgnet.com/1007-9327/full/v31/i30/110401.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i30.110401